Cargando…

Challenges and costs of donor screening for fecal microbiota transplantations

BACKGROUND: The increasing interest to perform and investigate the efficacy of fecal microbiota transplantation (FMT) has generated an urge for feasible donor screening. We report our experience with stool donor recruitment, screening, follow-up, and associated costs in the context of clinical FMT t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bénard, Mèlanie V., de Bruijn, Clara M. A., Fenneman, Aline C., Wortelboer, Koen, Zeevenhoven, Judith, Rethans, Bente, Herrema, Hilde J., van Gool, Tom, Nieuwdorp, Max, Benninga, Marc A., Ponsioen, Cyriel Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584411/ https://www.ncbi.nlm.nih.gov/pubmed/36264933 http://dx.doi.org/10.1371/journal.pone.0276323

Ejemplares similares

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes
por: Bénard, Mèlanie V., et al.
Publicado: (2023)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Shedding light on dark matter – faecal microbiota transplantation in Europe
por: Wortelboer, Koen, et al.
Publicado: (2021)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Drivers and determinants of strain dynamics following fecal microbiota transplantation
por: Schmidt, Thomas S. B., et al.
Publicado: (2022)

Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial
por: Zeevenhooven, Judith, et al.
Publicado: (2020)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
por: de Jonge, Patrick A., et al.
Publicado: (2022)

Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial
por: Fenneman, Aline C, et al.
Publicado: (2023)

Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Fecale microbiota transplantatie, meer dan een behandeling voor Clostridium difficile?
por: Nieuwdorp, Max
Publicado: (2020)

Fecal microbiota transplantation and fiber supplementation, better together?
por: Hanssen, Nordin M.J., et al.
Publicado: (2021)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
por: Scheithauer, Torsten P. M., et al.
Publicado: (2020)

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome
por: Koopen, Annefleur M., et al.
Publicado: (2021)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Species- and strain-level assessment using rrn long-amplicons suggests donor’s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
por: Benítez-Páez, Alfonso, et al.
Publicado: (2022)

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
por: Gilijamse, Pim W., et al.
Publicado: (2020)

The Super-Donor Phenomenon in Fecal Microbiota Transplantation
por: Wilson, Brooke C., et al.
Publicado: (2019)

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

A prospective study comparing patient-reported outcomes in Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2020)

Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)

Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)

Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
por: Galpérine, Tatiana, et al.
Publicado: (2023)

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
por: Nicco, Carole, et al.
Publicado: (2020)

Fecal microbiota transplantation in metabolic syndrome: History, present and future
por: de Groot, P. F., et al.
Publicado: (2017)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)

Power calculations for detecting differences in efficacy of fecal microbiota donors
por: Olesen, Scott W.
Publicado: (2020)

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

The fecal microbiota of healthy donor horses and geriatric recipients undergoing fecal microbial transplantation for the treatment of diarrhea
por: McKinney, Caroline A., et al.
Publicado: (2020)

Effect of Fiber and Fecal Microbiota Transplantation Donor on Recipient Mice Gut Microbiota
por: Zhong, Yifan, et al.
Publicado: (2021)

Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation
por: van Beurden, Yvette H., et al.
Publicado: (2017)

Framework for rational donor selection in fecal microbiota transplant clinical trials
por: Duvallet, Claire, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dlnbac2qeii029ck2aqgsbj9ci